|
|
| Twilight Litaka Pharma Limited |
|
Financials-Twilight Litaka Pharma Limited| Sector: Formulations | | BSE:6985 | NSE:TWILITAKA | Bloomberg:TLP@IN | Reuters:TWLP.BO | | Market Lot: 1 | Face Value: 5 | ISIN Demat: INE783B01029 |
|
|
| |
| Financials (Standalone) |
|
|
|
|
../financials/latestHalf.php
| Latest Quarterly/Halfyearly |
|
| As On(Months) |
31-Dec-2014(3) |
31-Dec-2013(3) |
% Change |
| Sales of Products/Services |
43.54 |
92.60 |
-52.98 |
| Other Operating Income |
0.00 |
0.00 |
-- |
| Other Income |
0.00 |
0.00 |
-- |
| Total Income |
43.54 |
92.60 |
-52.98 |
| Total Expenses |
20.92 |
103.21 |
-79.73 |
| OPBDIT |
22.62 |
-10.61 |
NM |
| Interest |
0.00 |
1.30 |
-- |
| Depreciation |
0.19 |
10.83 |
-98.25 |
| Exceptional & Extraordinary Items |
-187.52 |
0.00 |
-- |
| Prior Period Adjustments |
0.00 |
0.00 |
-- |
| Provision for Tax |
0.00 |
0.00 |
-- |
| After Tax Profit |
-165.09 |
-22.74 |
625.99 |
| Equity Capital |
123.91 |
123.91 |
0.00 |
| Reserves |
-165.09 |
7.29 |
NM |
| Notes to Accounts |
|
Click here |
|
|
| As on( Months ) |
31-Mar-05(12) |
|
31-Mar-04(12) |
|
31-Mar-03(12) |
|
| Profit / Loss A/C |
Rs mn |
%OI |
Rs mn |
%OI |
Rs mn |
%OI |
| Net Sales |
642.97 |
90.98 |
493.82 |
88.95 |
506.59 |
89.17 |
| Operating Income (OI) |
706.73 |
100.00 |
555.16 |
100.00 |
568.11 |
100.00 |
| OPBDIT |
41.63 |
5.89 |
60.34 |
10.87 |
36.84 |
6.48 |
| OPBDT |
3.20 |
0.45 |
15.57 |
2.81 |
-8.71 |
-1.53 |
| OPBT |
-9.47 |
-1.34 |
3.14 |
0.57 |
-20.70 |
-3.64 |
| Non-Operating Income |
16.80 |
2.38 |
1.77 |
0.32 |
1.73 |
0.30 |
| Extraordinary/Prior Period |
0.00 |
0.00 |
0.00 |
0.00 |
-0.28 |
-0.05 |
| Tax |
0.34 |
0.05 |
-0.64 |
-0.12 |
0.00 |
0.00 |
| Profit after tax(PAT) |
6.99 |
0.99 |
5.55 |
1.00 |
-19.26 |
-3.39 |
| Cash Profit |
19.67 |
2.78 |
17.99 |
3.24 |
-7.26 |
-1.28 |
| Dividend-Equity |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
0.00 |
|
| As on |
31-Mar-05 |
|
31-Mar-04 |
|
31-Mar-03 |
|
| Assets |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Gross Block |
212.36 |
51.15 |
195.23 |
42.67 |
194.06 |
54.75 |
| Net Block |
143.06 |
34.46 |
134.91 |
29.49 |
141.76 |
39.99 |
| Capital WIP |
8.66 |
2.09 |
7.15 |
1.56 |
5.09 |
1.44 |
| Investments |
0.61 |
0.15 |
0.61 |
0.13 |
0.21 |
0.06 |
| Inventory |
75.51 |
18.19 |
135.92 |
29.71 |
63.45 |
17.90 |
| Receivables |
137.68 |
33.16 |
132.62 |
28.98 |
97.03 |
27.37 |
| Other Current Assets |
49.67 |
11.96 |
46.35 |
10.13 |
46.92 |
13.24 |
| Balance Sheet Total(BT) |
415.18 |
100.00 |
457.57 |
100.00 |
354.47 |
100.00 |
| Liabilities |
Rs mn |
%BT |
Rs mn |
%BT |
Rs mn |
%BT |
| Equity Share Capital |
95.49 |
23.00 |
86.82 |
18.97 |
86.82 |
24.49 |
| Reserves |
-153.43 |
-36.95 |
-165.57 |
-36.18 |
-173.77 |
-49.02 |
| Total Debt |
308.64 |
74.34 |
316.99 |
69.28 |
317.56 |
89.59 |
| Creditors and Acceptances |
108.30 |
26.09 |
160.69 |
35.12 |
103.74 |
29.27 |
| Other current liab/prov. |
56.18 |
13.53 |
58.64 |
12.82 |
20.11 |
5.67 |
| Balance Sheet Total(BT) |
415.18 |
100.00 |
457.57 |
100.00 |
354.47 |
100.00 |
|
| As on |
31-Mar-05 |
31-Mar-04 |
31-Mar-03 |
| OPBIT/Prod.cap.empl.(%) |
11.99 |
20.78 |
11.02 |
| PBIT/Cap. Employed (%) |
18.90 |
21.49 |
11.66 |
| PAT/Networth (%) |
-12.07 |
-7.05 |
22.15 |
| Tax/PBT (%) |
4.58 |
-13.10 |
0.00 |
| Total Debt/Networth (x) |
-5.33 |
-4.03 |
-3.65 |
| Long Term Debt/Networth (x) |
-2.32 |
-1.81 |
-1.55 |
| PBDIT/Finance Charges (x) |
1.52 |
1.39 |
0.84 |
| Current Ratio (x) |
1.60 |
1.44 |
1.67 |
| RM Inventory (days consumption) |
28.83 |
113.13 |
33.94 |
| FG inventory (days cost of sales) |
27.66 |
19.12 |
22.21 |
| Receivables (days gross sales) |
72.16 |
87.15 |
62.73 |
| Creditors (days cost of sales) |
59.43 |
118.53 |
71.27 |
| Op. curr. assets (days OI) |
136.00 |
207.00 |
133.00 |
|
|
Financials